News & Updates

Allergic rhinitis can induce two types of symptoms in patients: i) histamine-mediated symptoms such as vasodilatation, rhinorrhoea, itching and sneezing, and ii) allergic inflammation resulting from the action of eosinophils in the nasal lining. H1-antihistamine therapy is a mode of therapy that seeks to mitigate the histamine-mediated symptoms of allergic rhinitis; this therapy aims to relieve symptoms and to improve quality of life in patients.

COVID-19 vaccination appears to be associated with a small increase in menstrual cycle length of less than 1 day, but these changes are only temporary and there is no change in the duration of menses, a prospective study suggests.

New drug applications approved by US FDA as of 16-31 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Treatment with icosapent ethyl did not reduce the rate of hospitalization or mortality among patients with SARS-CoV-2 infection, according to results of the PREPARE IT-2* trial presented at AHA 2021.

Receipt of a booster dose of the BNT162b2 mRNA vaccine is tied to a reduced risk of testing positive for SARS-CoV-2, according to results of a study from Israel.

Children with asthma who are infected with SARS-CoV-2 virus are at an increased risk of hospitalization, especially those whose asthma is poorly controlled, compared with children without asthma, according to data from the EAVE II* study.